Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma

Journal of Proteomics

Volumn 78, Issue , 2013, Pages 362-373

  Kimura, Kazuya ^a   Ojima, Hidenori ^a   Kubota, Daisuke ^a   Sakumoto, Marimu ^a   Nakamura, Yukiko ^a,b   Tomonaga, Tsuyoshi ^b   Kosuge, Tmoo ^c   Kondo, Tadashi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Biomarker; Hepatocellular carcinoma; Macrophage capping protein (CapG); Two dimensional difference gel electrophoresis; Venous invasion

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEINS AND BINDING PROTEINS; PROTEIN CAPG; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER METASTASIS; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

AGED; CARCINOMA, HEPATOCELLULAR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEOMICS;

EID: 84872684774     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.10.004     Document Type: Article

References (43)

1. Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002, 31:339-346.
2. Poon R.T., Fan S.T., Ng I.O., Lo C.M., Liu C.L., Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000, 89:500-507.
3. El-Assal O.N., Yamanoi A., Soda Y., Yamaguchi M., Yu L., Nagasue N. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery 1997, 122:571-577.
4. Monaco A.P. The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation 2009, 87:157-163.
5. Feng Y.X., Wang T., Deng Y.Z., Yang P., Li J.J., Guan D.X., et al. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology 2011, 53:483-492.
6. Mazzaferro V., Romito R., Schiavo M., Mariani L., Camerini T., Bhoori S., et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006, 44:1543-1554.
7. Qu L.S., Jin F., Huang X.W., Shen X.Z. Interferon-alpha therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma. J Surg Oncol 2010, 102:796-801.
8. Shimizu M., Takai K., Moriwaki H. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention. Cancer Sci 2009, 100:369-374.
9. Wang S.M., Zhu J., Pan L.F., Liu Y.K. Inhibitory effect of dimeric beta peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice. World J Gastroenterol 2008, 14:3054-3058.
10. Yokoo H., Kondo T., Okano T., Nakanishi K., Sakamoto M., Kosuge T., et al. Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. Cancer Sci 2007, 98:665-673.
11. Orimo T., Ojima H., Hiraoka N., Saito S., Kosuge T., Kakisaka T., et al. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology 2008, 48:1851-1863.
12. Budhu A., Forgues M., Ye Q.H., Jia H.L., He P., Zanetti K.A., et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006, 10:99-111.
13. Wong C.M., Wong C.C., Lee J.M., Fan D.N., Au S.L., Ng I.O. Sequential alterations of miRNA expression in hepatocellular carcinoma development and venous metastasis. Hepatology 2012, 55:1453-1461.
14. Kondo T., Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 2007, 1:2940-2956.
15. Morofuji N., Ojima H., Onaya H., Okusaka T., Shimada K., Sakamoto Y., et al. Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. J Proteomics 2012, 75:1577-1589.
16. Dahl E., Sadr-Nabavi A., Klopocki E., Betz B., Grube S., Kreutzfeld R., et al. Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol 2005, 205:21-28.
17. Thompson C.C., Ashcroft F.J., Patel S., Saraga G., Vimalachandran D., Prime W., et al. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 2007, 56:95-106.
18. Lal A., Lash A.E., Altschul S.F., Velculescu V., Zhang L., McLendon R.E., et al. A public database for gene expression in human cancers. Cancer Res 1999, 59:5403-5407.
19. Van Ginkel P.R., Gee R.L., Walker T.M., Hu D.N., Heizmann C.W., Polans A.S. The identification and differential expression of calcium-binding proteins associated with ocular melanoma. Biochim Biophys Acta 1998, 1448:290-297.
20. Nomura H., Uzawa K., Ishigami T., Kouzu Y., Koike H., Ogawara K., et al. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity. BMC Cancer 2008, 8:39.
21. Renz M., Betz B., Niederacher D., Bender H.G., Langowski J. Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG. Int J Cancer 2008, 122:1476-1482.
22. Utsunomiya T., Shimada M., Taguchi K.I., Hasegawa H., Yamashita Y., Hamatsu T., et al. Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma. J Am Coll Surg 2000, 190:331-335.
23. Paquet K.J., Gad H.A., Lazar A., Koussouris P., Mercado M.A., Heine W.D., et al. Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg 1998, 164:513-519.
24. Schoniger-Hekele M., Muller C., Kutilek M., Oesterreicher C., Ferenci P., Gangl A. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 2001, 48:103-109.
25. Casella J.F., Maack D.J., Lin S. Purification and initial characterization of a protein from skeletal muscle that caps the barbed ends of actin filaments. J Biol Chem 1986, 261:10915-10921.
26. Shao F., Zhang R., Don L., Ying K. Overexpression of gelsolin-like actin-capping protein is associated with progression of lung adenocarcinoma. Tohoku J Exp Med 2011, 225:95-101.
27. Zhu W.Y., Hunag Y.Y., Liu X.G., He J.Y., Chen D.D., Zeng F., et al. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and topo-II proteins in non-small cell lung cancer. Anat Rec (Hoboken) 2012, 295:208-214.
28. Wu J.H., Tian X.Y., Hao C.Y. The significance of a group of molecular markers and clinicopathological factors in identifying colorectal liver metastasis. Hepatogastroenterology 2011, 58:1182-1188.
29. Kang S., Kim M.J., An H., Kim B.G., Choi Y.P., Kang K.S., et al. Proteomic molecular portrait of interface zone in breast cancer. J Proteome Res 2010, 9:5638-5645.
30. Xu S.G., Yan P.J., Shao Z.M. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. J Cancer Res Clin Oncol 2010, 136:1545-1556.
31. Partheen K., Levan K., Osterberg L., Claesson I., Fallenius G., Sundfeldt K., et al. Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. Int J Cancer 2008, 123:2130-2137.
32. Li M.X., Xiao Z.Q., Chen Y.H., Peng F., Li C., Zhang P.F., et al. Proteomic analysis of the stroma-related proteins in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues. Med Oncol 2010, 27:134-144.
33. Watari A., Takaki K., Higashiyama S., Li Y., Satomi Y., Takao T., et al. Suppression of tumorigenicity, but not anchorage independence, of human cancer cells by new candidate tumor suppressor gene CapG. Oncogene 2006, 25:7373-7380.
34. Pierce A., Unwin R.D., Evans C.A., Griffiths S., Carney L., Zhang L., et al. Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases. Mol Cell Proteomics 2008, 7:853-863.
35. Liao S.H., Zhao X.Y., Han Y.H., Zhang J., Wang L.S., Xia L., et al. Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells. Proteomics 2009, 9:3901-3912.
36. Chen M., Sinha M., Luxon B.A., Bresnick A.R., O'Connor K.L. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem 2009, 284:1484-1494.
37. Bahassi el M., Karyala S., Tomlinson C.R., Sartor M.A., Medvedovic M., Hennigan R.F. Critical regulation of genes for tumor cell migration by AP-1. Clin Exp Metastasis 2004, 21:293-304.
38. Huynh H., Ong R.W., Li P.Y., Lee S.S., Yang S., Chong L.W., et al. Targeting receptor tyrosine kinase pathways in hepatocellular carcinoma. Anticancer Agents Med Chem 2011, 11:560-575.
39. Kong J., Pan B., Ke S., Dong S., Li X., Zhou A., et al. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1alpha/VEGFA. PLoS One 2012, 7:e37266.
40. Bergamini C., Sgarra C., Trerotoli P., Lupo L., Azzariti A., Antonaci S., et al. Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins. Hepatology 2007, 46:1801-1809.
41. Guo L.L., Xiao S., Guo Y. Activation of transcription factors NF-kappaB and AP-1 and their relations with apoptosis associated-proteins in hepatocellular carcinoma. World J Gastroenterol 2005, 11:3860-3865.
42. Tonack S., Patel S., Jalali M., Nedjadi T., Jenkins R.E., Goldring C., et al. Tetracycline-inducible protein expression in pancreatic cancer cells: effects of CapG overexpression. World J Gastroenterol 2011, 17:1947-1960.
43. Zheng Z., Li J., He X., Chen X., Yu B., Ji J., et al. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil. Hepatogastroenterology 2010, 57:1106-1112.